Skip to content
November 5, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • Bridging the Gap in Women’s Health: CAKES Body Extends Landmark Partnership with BCRF to Fund Research for Younger Women
  • Patient Advocacy and Support

Bridging the Gap in Women’s Health: CAKES Body Extends Landmark Partnership with BCRF to Fund Research for Younger Women

Asep Darmawan November 5, 2026 8 minutes read
bridging-the-gap-in-womens-health-cakes-body-extends-landmark-partnership-with-bcrf-to-fund-research-for-younger-women

NEW YORK — In a significant move that underscores the growing intersection between consumer brands and specialized medical research, CAKES body has announced an extension of its high-impact partnership with the Breast Cancer Research Foundation (BCRF). The brand has committed a minimum of $250,000 through June 2027, specifically earmarked for the "She’s Not Too Young" research fund. This new pledge builds upon a foundation of philanthropy that has already seen the brand donate over $1.5 million to women’s health causes since its inception just two years ago.

The collaboration aims to address a critical and often overlooked demographic in oncology: women under the age of 50. By focusing on research, education, and survivorship support for younger patients, CAKES body and BCRF are working to dismantle the "too young for cancer" myth that frequently leads to delayed diagnoses and poorer outcomes for this population.

Main Facts: A Renewed Commitment to Life-Saving Science

The cornerstone of this announcement is the $250,000 minimum commitment, which will be funneled into the She’s Not Too Young: A CAKES body x BCRF Fund for Younger Women with Breast Cancer. This fund was established to support the full spectrum of BCRF’s research portfolio. Unlike many charitable initiatives that focus solely on awareness, this partnership is designed to produce tangible scientific data across four key pillars:

  1. Prevention: Identifying environmental and genetic factors that contribute to early-onset breast cancer.
  2. Risk Assessment: Developing better screening protocols for women who fall below the standard mammogram age of 40 or 50.
  3. Treatment Innovations: Tailoring therapies to the specific biological profiles of tumors found in younger women, which are often more aggressive.
  4. Survivorship Support: Addressing the unique long-term needs of younger survivors, including fertility preservation, early menopause, and psychological impact.

Beyond the monetary pledge, the partnership includes a multifaceted retail component. CAKES is launching a limited-edition "Give Back Bundle," with 30% of revenue (up to $50,000) going directly to BCRF. Furthermore, the brand is leveraging its product line to provide direct aid to those who have undergone mastectomies and reconstructions. For the first 6,000 bundles sold, CAKES will donate a pair of "CAKES with Nips"—specialized nipple covers designed in collaboration with breast cancer "thrivers"—to organizations serving survivors and those living with metastatic breast cancer.

Chronology: From Startup Success to Philanthropic Powerhouse

The trajectory of CAKES body is a testament to the speed at which modern "purpose-driven" brands can achieve scale. To understand the significance of the new $250,000 commitment, one must look at the brand’s rapid evolution:

  • 2022: The Genesis: CAKES body was founded by sisters Casey Sarai and Taylor Capuano. Originally envisioned as a solution for women seeking comfortable, "grippy" (non-adhesive) bra alternatives, the brand quickly found an unexpected but loyal following among breast cancer patients. These women found the soft, medical-grade silicone products ideal for sensitive skin post-radiation and surgery.
  • Early 2023: Identifying the Need: After receiving a deluge of feedback from the "thriver" community, the founders realized their products were serving a medical necessity. They began integrating breast health education into their marketing and identified BCRF as their primary philanthropic partner.
  • Late 2023: The $400,000 Launch: CAKES body made headlines by pledging $400,000 to launch the She’s Not Too Young fund. This was one of the largest inaugural commitments to BCRF by a startup in recent history, establishing the brand as a major player in the breast cancer advocacy space.
  • 2024: Expansion and Innovation: Following the success of the initial fund, the brand collaborated with survivors to create "CAKES with Nips," a product specifically requested by women who had lost their nipples during mastectomy and reconstruction.
  • June 2024: The New Commitment: Recognizing that the fight against early-onset breast cancer requires long-term investment, CAKES body officially extended its commitment with the additional $250,000 pledge through 2027.

Supporting Data: Why the "Younger Women" Focus Matters

The "She’s Not Too Young" initiative is grounded in sobering clinical data. While breast cancer is often framed as a disease of older age, the statistics for younger women tell a different story:

The Rising Incidence

Recent studies have shown a concerning uptick in breast cancer diagnoses among women under 50. According to the American Cancer Society, while overall breast cancer death rates have decreased, the incidence rate has increased by about 0.5% per year since the mid-2000s, with a more pronounced rise in younger cohorts.

Biological Aggression

Breast cancers diagnosed in younger women are more likely to be "triple-negative" or HER2-positive—subtypes that are typically more aggressive and have a higher risk of recurrence. Because younger women often have denser breast tissue, standard mammography is less effective, frequently leading to cancers being discovered at a later, more advanced stage.

The Social and Economic Toll

Women diagnosed in their 20s, 30s, and 40s are often at the peak of their careers or in the middle of raising young families. The financial toxicity of treatment, coupled with the long-term side effects of hormone therapy on fertility and bone health, creates a unique set of challenges that traditional research has often sidelined.

By funding BCRF’s research, CAKES body is specifically targeting these data gaps. The $1.5 million already donated by the brand has contributed to thousands of hours of lab work aimed at understanding why these tumors behave differently in younger bodies.

Official Responses: A Mission-Driven Partnership

The leadership at CAKES body views their philanthropic work not as a secondary corporate social responsibility (CSR) initiative, but as the core of their business model.

Taylor Capuano, Co-founder of CAKES body, emphasized the importance of the brand’s community-first approach:
"CAKES was built by listening to women, talking openly about their bodies, and creating solutions for issues that too often get overlooked or treated as uncomfortable. That responsibility has grown along with our company. We didn’t just want to sell a product; we wanted to provide a solution for the women who told us our products made them feel whole again after surgery."

Anna Crollman, Director of Brand Marketing at CAKES body, who is herself a breast cancer survivor and advocate, highlighted the forward-looking nature of the investment:
"At CAKES, we believe investing in this research will change the future for women facing breast cancer today and tomorrow. We aren’t just funding treatment for the current generation; we are looking for the ‘why’ and the ‘how’ to prevent this from happening to the next generation."

Representatives from BCRF have lauded the partnership for its specific focus. In previous statements regarding the fund, BCRF leadership noted that corporate partners like CAKES are essential because they provide "flexible" funding that allows researchers to pursue high-risk, high-reward inquiries into early-onset cancer that government grants might overlook.

Implications: The Future of Corporate Advocacy and Women’s Health

The extension of this partnership has several broad implications for the fashion and wellness industries, as well as the medical community.

1. The "Community-to-Clinic" Feedback Loop

CAKES body has successfully demonstrated a new model of product development where feedback from a specific medical sub-community (breast cancer survivors) leads to both product innovation ("CAKES with Nips") and targeted philanthropy. This creates a virtuous cycle where consumer purchases directly fund the research that benefits those same consumers.

2. Normalizing the Conversation

By naming the fund "She’s Not Too Young," the brand is using its massive social media presence to educate a younger audience about breast self-awareness. This "knowledge is power" approach helps break the stigma surrounding breast health in younger demographics, potentially leading to earlier detection.

3. Setting a Benchmark for Startups

In an era where "pinkwashing" (using breast cancer symbols for profit without significant contribution) is frequently criticized, CAKES body’s $1.5 million total contribution sets a high bar for other startups. Their commitment is transparent, long-term, and tied to specific research goals rather than just general awareness.

4. Advancing Reconstruction Equity

The donation of 6,000 "CAKES with Nips" addresses a niche but vital aspect of survivorship: body image. For many women, the loss of nipples during a mastectomy is a profound psychological blow. By providing high-quality, realistic alternatives to those in need, CAKES is addressing the "survivorship" pillar of BCRF’s mission in a tangible, immediate way.

Conclusion

The $250,000 commitment from CAKES body to the Breast Cancer Research Foundation represents more than just a financial transaction; it is a strategic investment in the future of oncology. By focusing on the unique biological and social needs of younger women, the "She’s Not Too Young" fund is filling a critical void in the global research landscape. As the brand continues to grow, its fusion of innovative product design and serious scientific funding provides a roadmap for how modern companies can play a pivotal role in solving the world’s most pressing health crises.

About the Author

Asep Darmawan

Author

View All Posts

Post navigation

Previous: Fragile Foundations: How the COVID-19 Pandemic Severed Global Access to Essential Healthcare

Related Stories

a-pilots-resilience-navigating-the-uncharted-skies-of-metastatic-breast-cancer
  • Patient Advocacy and Support

A Pilot’s Resilience: Navigating the Uncharted Skies of Metastatic Breast Cancer

Evan Lee Salim November 4, 2026
Scientists working with samples in laboratory
  • Patient Advocacy and Support

The Dawn of a New Era: Breakthroughs and Advocacy in Metastatic Breast Cancer Research

Rifan Muazin November 4, 2026
navigating-the-unthinkable-guiding-children-through-the-reality-of-a-loved-ones-terminal-illness
  • Patient Advocacy and Support

Navigating the Unthinkable: Guiding Children Through the Reality of a Loved One’s Terminal Illness

Raul Delapena Setiawan November 4, 2026

Recent Posts

  • Bridging the Gap in Women’s Health: CAKES Body Extends Landmark Partnership with BCRF to Fund Research for Younger Women
  • Fragile Foundations: How the COVID-19 Pandemic Severed Global Access to Essential Healthcare
  • The GLP-1 Arms Race: Novo Nordisk Defends Territory Amidst Shifting Market Dynamics
  • Zimmer Biomet Surges as Strategic Pivot Drives Strong Q3 Performance and Elevated 2026 Outlook
  • PharmSci 360 2026: Pioneering a New Era of Research Integrity and Post-Animal Innovation

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

bridging-the-gap-in-womens-health-cakes-body-extends-landmark-partnership-with-bcrf-to-fund-research-for-younger-women
  • Patient Advocacy and Support

Bridging the Gap in Women’s Health: CAKES Body Extends Landmark Partnership with BCRF to Fund Research for Younger Women

Asep Darmawan November 5, 2026
fragile-foundations-how-the-covid-19-pandemic-severed-global-access-to-essential-healthcare
  • Breast Cancer Prevention and Lifestyle

Fragile Foundations: How the COVID-19 Pandemic Severed Global Access to Essential Healthcare

Nana Wu November 5, 2026
the-glp-1-arms-race-novo-nordisk-defends-territory-amidst-shifting-market-dynamics
  • Treatment Innovations

The GLP-1 Arms Race: Novo Nordisk Defends Territory Amidst Shifting Market Dynamics

Iffa Jayyana November 5, 2026
zimmer-biomet-surges-as-strategic-pivot-drives-strong-q3-performance-and-elevated-2026-outlook
  • Treatment Innovations

Zimmer Biomet Surges as Strategic Pivot Drives Strong Q3 Performance and Elevated 2026 Outlook

Sagoh November 5, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.